Skip to content

Viridian Therapeutics, Inc. VRDN Prepaid & Other Current

Prepaid & Other Current at other companies

Amgen logo
AmgenAMGN
$4.11B+26.2%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$42.76M-16.4%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$22.09M-5.3%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$44.76M+5.6%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$20.44M+81.2%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$16.1M+90.3%

Other financials

Income statement

See full
Revenue$141.0K+95.8%
Operating income-$116.2M-23.8%
Net income-$104.9M-20.7%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$176.3M+51.7%
Total debt$36.8M+59.4%
Total equity$636.0M+5.2%
Total assets$789.0M+19.4%

Cash flow

See full
Operating cash flow-$119.7M-29.1%
CapEx$23.0K-73.3%
Free cash flow-$119.7M-29.0%

Valuation

See full
Market cap$1.91B+82.0%
Enterprise value$1.77B+85.0%
P/S26.9×-3,445×

Profitability

See full
Gross margin36.3%
Operating margin-543.9%-271pp
Net margin-508.5%-254pp
FCF margin-428.4%-214pp

Returns & leverage

See full
Return on equity-58.1%+7.9pp
Debt / equity0.1×0.0×
Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s prepaid & other current?
Viridian Therapeutics, Inc. (VRDN) reported prepaid & other current of $22.56M in Q1 2026.
How has Viridian Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Viridian Therapeutics, Inc.'s prepaid & other current increased by 9.5% year-over-year, from $20.61M to $22.56M.
What is the long-term trend for Viridian Therapeutics, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s prepaid & other current has grown at a 58.3% compound annual growth rate (CAGR), from $1.97M to $19.58M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.